Moderate hypofractionated radiotherapy for post-operative treatment of prostate cancer: long-term outcome and pattern of toxicity

ConclusionOur results confirm the long-term safety and efficacy of postoperative MHRT for PC.Advances in knowledgeThe present paper demonstrates the long-term safety and efficacy of MHRT for postoperative prostate cancer. Reduction of treatment time in long-course radiotherapy has advantages in terms of both patients ’ quality of life and departmental organization.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research